Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours Β· Estimated delivery Aug 27 - Sep 1
134978-97-5, NH2-PEG2-CH2COOH CAS No
Recently, the FDA added an indication, allowing it to be used to help patients lose weight
GLP-1 receptor agonist medications (including semaglutide, dulaglutide, liraglutide, exenatide, and lixisenatide) are typically considered for type 2 diabetes when: Triple therapy with other diabetes medications is not effective, not tolerated, or contraindicated The person has a BMI 35 kg/m (adjusted by 2.5 kg/m for people from South Asian, Chinese, other Asian, Black African, or African-Caribbean backgrounds) and specific weight-related psychological or medical problems A lower BMI threshold may be appropriate if weight loss would benefit other obesity-related comorbidities Insulin would not be appropriate or acceptable to the person Treatment is usually continued only if there is a beneficial metabolic response (reduction in HbA1c and weight) after 6 months
Stop taking the medication immediately and call your physician
Light pressure is all you need
US$ 25.20
US$ 25.23
US$ 24.89
US$ 25.38
US$ 29.72
US$ 22.20
US$ 20.10
